Shilpa Medicare starts functioning partially at Pharma Park Jadcherla, AP

12 Jun 2013 Evaluate

Shilpa Medicare’s State of art facility at Pharma Park Jadcherla (SEZ), near Mahaboobnagar (AP) for undertaking ‘Contract Research & Forward Integration i.e. Own Formulation’ (Manufacturing of Oral & Injectible (Onco Products) has started functioning partially. Facility for manufacture of Formulation section will commence commercial production in stages after successful completion of trial production/stability tests etc. which is underway.

The Company had visualized Contract Research as one of the thrust area few years back. It invested in creating Research & Development Centres at two places. The investment has started yielding results. It expects that this will grow in time to come and would become an important source of income, besides inventing new/improved products for the Company.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.  

Shilpa Medicare Share Price

922.95 -12.85 (-1.37%)
22-Nov-2024 12:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1781.65
Dr. Reddys Lab 1211.10
Cipla 1487.05
Lupin 2060.10
Zydus Lifesciences 947.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.